Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2022-09-09
2024-07-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Repetitive transcranial magnetic stimulation (rTMS), which is a safe, non-invasive brain stimulation technique has emerged as a potential treatment for chronic pain. In this study, the purpose is to explore the potential of rTMS in treating the persistent neuropathic pain by providing individualized treatment for the sufferers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders.
NCT06813040
Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain
NCT03263884
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
NCT05593237
Analgesic Effects of rTMS in Peripheral Neuropathic Pain
NCT02010281
Analgesic Effect of Non Invasive Stimulation : Comparison of rTMS and tDCS Efficacy
NCT01800136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this project, people with PTNP (N=9) received a rTMS (50 Hz, 600 pulses for 40s) session/week as intervention for four consecutive weeks at the primary somatosensory cortex (face area) in a "n-of-1" single-blinded randomized controlled cross-over design: (A) active-sham-active-sham or (B) sham-active-sham-active. That is the same participant received both active and sham either in the (A) order or (B). Pain intensity and perceptual distortion (PD) as perceived size changes of the affected face area were measured at baseline, immediately, 60 mins after rTMS in each session and end of the session (a week after rTMS), one and three months after rTMS. Questionnaires on quality of life, jaw function, sleep quality were also assessed. Changes in pain and PD after each intervention were evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active group
Continuous theta burst stimulation
Active repetitive transcranial magnetic stimulation (rTMS)
cTBS (50 Hz, 600 pulses, 80% resting motor threshold) for 40s was applied continuously as active rTMS at the face representation area of primary somatosensory cortex (S1)
Sham group
Sham repetitive transcranial magnetic stimulation (rTMS)
Sham repetitive transcranial magnetic stimulation (sham rTMS)
A sham rTMS was applied using the same stimulation parameters as with cTBS, but using a placebo coil, which produced similar sound as the real coil.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active repetitive transcranial magnetic stimulation (rTMS)
cTBS (50 Hz, 600 pulses, 80% resting motor threshold) for 40s was applied continuously as active rTMS at the face representation area of primary somatosensory cortex (S1)
Sham repetitive transcranial magnetic stimulation (sham rTMS)
A sham rTMS was applied using the same stimulation parameters as with cTBS, but using a placebo coil, which produced similar sound as the real coil.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable on analgesic medication
Exclusion Criteria
* Major stroke
* Pregnancy
* Severe organic brain damage
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simple F Kothari, BDS, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Aarhus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dentistry and Oral Health
Aarhus C, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kothari SF, Dagsdottir LK, Kothari M, Blicher JU, Kumar A, Buchholtz PE, Ashkanian M, Svensson P. Effect of repetitive transcranial magnetic stimulation on altered perception of One's own face. Brain Stimul. 2020 May-Jun;13(3):554-561. doi: 10.1016/j.brs.2020.01.001. Epub 2020 Jan 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5771
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.